RECENT NEWS

The European Society of Cardiology (ESC) marks 75 years of advancing cardiovascular medicine and improving heart health worldwide - a milestone that will be celebrated at ESC Congress 2025, taking place in Madrid from 29 August to 1 September.

A free to join webinar taking place later this month will be encouraging medical device innovators to learn more about new Post-Market Surveillance (PMS) legislation and how to successfully navigate it.

A new report has revealed a paradox at the heart of the NHS workforce crisis: healthcare has surged into the top two career choices among teenagers in England – yet it is not translating into jobs, as the NHS continues to face a £2 billion annual agency staffing bill to fill empty roles.

Better Meds and BD have partnered to integrate BD Pyxis automated dispensing cabinets (ADC) with Better Meds’ electronic prescribing and medicines administration (ePMA) system. The partnership will ensure safer and more efficient medication administration than manual processes on hospital wards, in collaboration with University Hospitals Plymouth NHS Trust.

An individual from the UK has died after becoming infected with rabies, following contact with a stray dog during a visit to Morocco. The individual was diagnosed in Yorkshire and the Humber.

The government has published new guidelines for health and care providers to train staff, so that people with a learning disability and autistic people will get safer, more personalised care.

Millions of people will now be able to search for and sign up to life-changing clinical trials, via the National Institute for Health and Care Research (NIHR) Be Part of Research service on the NHS App, allowing patients to browse and find the trials best suited to their interests and needs.

Patients with sickle cell disease are set to benefit from quicker and more accessible treatment thanks to major upgrades to life-saving technology.

A fresh £6bn available through the Horizon Europe programme could be ‘utterly transformative for healthcare innovation and net zero ambitions,’ says a formal NHS Scotland partner.

Up to 4 million additional tests, scans and procedures will be delivered across the UK as the Chancellor has confirmed £6 billion of investment over the next five years in Britain’s health.

Guy’s and St Thomas’ NHS Foundation Trust has announced the launch of the Proactive & Accessible Transformation of Healthcare (PATH) initiative in collaboration with General Catalyst, NVIDIA, Hippocratic AI, and Sword Health.

As the population ages, and the number of cancer diagnoses increases, the incidence of cardiovascular side effects from treatment also rises. To address this growing challenge, ESC Cardio-Oncology 2025, a new conference focused on this vital area, will take place in Florence, Italy, on 20 and 21 June 2025.

Researchers are investigating how to improve the quality of life of women returning to work after breast cancer, thanks to new funding from Breast Cancer Now.

The current system of elective care is struggling to inform patients of their rights to choose healthcare providers and procedures, and offering little information or support when decisions need to be made, according to a new report.

Millions more patients will receive appointment reminders, screening invitations and test results directly to their smartphones as the NHS turbocharges its digital revolution to make it easier for patients to access care.

The NHS waiting list has fallen to its lowest level in two years, the first April drop since 2008, as health chiefs hailed staff for continuing to tackle demand and drive progress for patients.

Millions of patients will benefit from cutting-edge NHS robotic surgery over the next decade as part of radical plans to cut waiting times. Half a million operations will be supported with this approach, every year by 2035, up from 70,000 in 2023/24, according to NHS projections.

A new digital hub in Leeds is being launched by the Medicines and Healthcare products Regulatory Agency (MHRA), marking a significant step in the agency’s long-term commitment to advancing innovation and strengthening its presence across the UK.

The Medicines and Healthcare products Regulatory Agency (MHRA) has published the UK’s first official guidance to support the safe development and use of phage therapies – treatments that use viruses to target and destroy harmful bacteria.

Randox Laboratories has announced that the US Food and Drug Administration (FDA) has approved the De Novo application for the company’s first Companion Diagnostic (CDx). This is a major achievement for Randox following over three years of innovative development and collaboration with Novo Nordisk. The Companion Diagnostic was developed as a new option for determining the amount of medication a patient with haemophilia has received.